Valuation Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:11:23 2026-07-15 am EDT			5-day change	1st Jan Change
2,651.05 ^INR	-0.26%		+4.90%	+43.98%

May. 14	Caplin Point Laboratories Limited, Q4 2026 Earnings Call, May 14, 2026
May. 14	Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	30,571	51,529	45,291	100,038	152,221	201,511	-	-
Change	-	68.55%	-12.11%	120.88%	52.16%	32.38%	-	-
Enterprise Value (EV)	30,571	51,529	45,291	100,038	152,221	201,511	201,511	201,511
Change	-	68.55%	-12.11%	120.88%	52.16%	32.38%	0%	0%
P/E	12.7x	17.3x	12.1x	22x	28.5x	17.9x	28.3x	24.8x
PBR	2.58x	3.47x	2.41x	4.32x	5.34x	3.19x	4.58x	4.16x
PEG	-	0.7x	0.5x	1x	1.6x	0.9x	1.8x	1.8x
Capitalization / Revenue	2.88x	4.06x	3.09x	5.91x	7.86x	5.23x	8.1x	7.18x
EV / Revenue	0x	0x	0x	0x	0x	9.47x	8.1x	7.18x
EV / EBITDA	0x	0x	0x	0x	0x	27.2x	23.4x	20.5x
EV / EBIT	0x	0x	0x	-	0x	25.9x	21.6x	18.7x
EV / FCF	0x	0x	0x	0x	0x	53x	36.6x	37.2x
FCF Yield	6.39%	4.77%	1.72%	1.73%	1.58%	2.4%	2.73%	2.69%
Dividend per Share ²	3	2	2	2.5	3	-	4	4
Rate of return	0.74%	0.29%	0.34%	0.19%	0.15%	-	0.15%	0.15%
EPS ²	31.71	39.26	49.18	59.9	70.25	84.11	93.8	107
Distribution rate	9.46%	5.09%	4.07%	4.17%	4.27%	-	4.26%	3.74%
Net sales ¹	10,613	12,694	14,667	16,941	19,375	21,872	24,880	28,053
EBITDA ¹	3,286	3,947	4,411	5,514	6,469	7,609	8,604	9,810
EBIT ¹	3,152	3,478	4,520	-	5,810	8,036	9,321	10,752
Net income ¹	2,423	2,998	3,763	4,571	5,363	6,412	7,128	8,124
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	404.15	679.90	596.70	1,317.30	2,002.60	2,651.05	2,651.05	2,651.05
Nbr of stocks (in thousands)	75,643	75,789	75,903	75,942	76,012	76,012	-	-
Announcement Date	5/6/21	5/12/22	5/27/23	5/16/24	5/15/25	5/14/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CAPLIN POINT LABORATORIES LIMITED	32.78x	-	-	-	2.1B
SUN PHARMACEUTICAL INDUSTRIES LTD.	35.47x	6.71x	23.18x	0.82%	48.52B
OTSUKA HOLDINGS CO., LTD.	18.22x	2.05x	9.67x	1.32%	35.68B
CIPLA LIMITED	27.65x	3.42x	17.51x	0.85%	12.09B
ZYDUS LIFESCIENCES LIMITED	26.87x	3.96x	16.13x	0.59%	11.77B
KRKA, D. D.	19.4x	3.39x	12.19x	3.43%	9.19B
ONO PHARMACEUTICAL CO., LTD.	16.25x	2.09x	7.04x	3.22%	7.06B
GEDEON RICHTER	8.4x	1.97x	5.17x	5.16%	7.01B
GLENMARK PHARMACEUTICALS LIMITED	34.99x	3.99x	16.99x	0.23%	6.77B
Average	24.45x	3.45x	13.48x	1.95%	15.58B
Weighted average by Cap.	26.25x	4.15x	15.82x	1.42%